GBA Presents: RADIO SAVANT-!

vanzandt said:
Stoney!

Buy this stock on a pull-back.

Stride
$LRN

It closed at 37.79. They had a great report.
I had never heard of them, off the radar type company.
It's a good one though.
$41 after hours.

Hopefully it'll drop back a little, but I doubt it will after that report.
The company is in the right sector, and it looks like it's very well run.
Books are solid. Based in Reston, VA -- so you know what that means... they like feeding at Uncle Sam's trough, and this is actually a business outside defense that does some good with all that pork.
Great sector to be in going forward.

Check em out.

Rare "VZ STRONG UPGRADE"

LRN
More...
Fwiw.... for all the original DD I put into this one early on... no cut and pastes from the various web based pump and dump sites... just a stock no one had ever heard of before.
LRN--->$61.04
You're welcome.
 
vanzandt said:
Fwiw.... for all the original DD I put into this one early on... no cut and pastes from the various web based pump and dump sites... just a stock no one had ever heard of before.
LRN--->$61.04
You're welcome.
More...
Already bought, will post my DAL at $30.80 Oct 27th 10:59 AM buy date, I do listen!

Edited: LRN and GEO thesis, I will post later.
 
I think we should move on Checkpoint- I'm no Dr but when a drug is rejected because of a manufacturing issue.. that can be fixed.


UPDATE 1-US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy
December 18, 2023
In this article:
CKPT
+6.42%

Dec 18 (Reuters) - Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration declined to approve its experimental therapy to treat a type of advanced skin cancer, citing issues related to a third-party contract manufacturer.

The company filed the marketing application for the drug, Cosibelimab, its lead therapy in development, earlier this year.

Checkpoint said the FDA did not state any concerns about the data or safety on the drug in its so-called complete response letter.

"We believe we can address the feedback in a resubmission to enable marketing approval in 2024," said CEO James Oliviero said in a statement

The trial data showed the therapy helped reduce or clear cancerous tumors by 47.4%.
 
I kind of Savant thought this out last week. I held off because we had a run with OTLK and I didn't want to fish too much in the low priced swamp of Bios.. Capital raising and all that....

Checkpoint Therapeutics, Inc. (CKPT)
NasdaqCM - NasdaqCM Real Time Price.
2.3072+0.1272 (+5.83%)
As of 01:39PM EST.
 
stonedinvestor said:
I kind of Savant thought this out last week. I held off because we had a run with OTLK and I didn't want to fish too much in the low priced swamp of Bios.. Capital raising and all that....

Checkpoint Therapeutics, Inc. (CKPT)
NasdaqCM - NasdaqCM Real Time Price.
2.3072+0.1272 (+5.83%)
As of 01:39PM EST.
More...
:rolleyes:
A whole 12.72 pennies?!
With a 3 cent spread? :banghead:

That's the beauty of penny stocks Stoney.... you can act the guru on a one dime move... and the newbies say "wow".... but get back to us with that on a stock above $100 and we might give a f.
 
STONEY!!!!

It's the one month anniversary of "the great correction".... the one you made 100 posts bragging about how great your timing is... and yet I see the the DOW and S&P closed at all time highs today. The Naz was close. Dead wrong Stoney. Looks like both you and Cramer were wrong. I'm not gloating, but I told you so.
~Whatever.

vanzandt said:
Put buying for January opex has been pretty high, I'd imagine any significant pull-back will occur after that.
;)
More...

That was today. The day that all-time highs were set. Imagine that.
Now you can be slightly bearish.

---> You're welcome.:sneaky:
 
You must log in or register to reply here.
Back
Top